A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Grants and Contracts Details

StatusFinished
Effective start/end date4/11/13 → 12/31/14

Funding

  • AbbVie Incorporated: $27,949.00